MEDP
Medpace Holdings, Inc.
Platform & Compounding FCF
A+
94.9 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
43.2%
-
Operating Margin Trend
+0.96 pp/yr
-
5yr Avg ROE
68.2%
-
5yr Share-Count CAGR
-5.9%
-
5yr Revenue CAGR
22.0%
-
5yr EPS CAGR
33.5%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
23.9%
-
5yr FCF/NI Conversion
1.41x
-
Net Debt / EBITDA
-0.43x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
7.68
Stability
Weight: 5%
C-
51
-
EPS Volatility (σ/μ)
0.86
-
Piotroski F-Score
7
-
Negative-Revenue Years (5)
0/5
4 of 4 gurus held; 2 added; 2 trimmed.
- Holders
- 4
- Avg Δ position
-
+6.4%
- New buys
- 0
- Full exits
- 0